Identification of Potential Therapeutic Genes and Pathways in Phytoestrogen Emodin Treated Breast Cancer Cell Lines via Network Biology Approaches

Date

2021-02-01

Author

Sakalli-Tecim, Elif
Uyar-Arpaci, Pembegul
Güray, Nülüfer Tülün

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

194
views

0
downloads

Phytoestrogens have been investigated for their potential anti-tumorigenic effects in various cancers including breast cancer. Emodin being a phytoestrogen shows anti-carcinogenic properties especially in estrogen receptor positive (ER+) breast cancers. The aim of this study is to identify the molecular mechanism and related biological pathways in both (ER+) MCF-7 and (ER-) MDA-MB-231 breast cancer cell lines upon Emodin treatment via microarray analysis in order to find out therapeutic biomarkers. In both cell lines, first differentially expressed genes were identified, then gene ontology and functional pathway enrichment analyses were performed. Genes regulated through multiple pathways were studied together with literature and a gene cluster was determined for each cell line. Further GeneMANIA and STRING databases were used to study the interactions within the related gene clusters. The results showed that, the genes which are related to cell cycle were significantly regulated in both cell lines. Also, Forkhead Box O1-related genes were found to be prominent in MCF-7 cells. In MDA-MB-231 cells, spindle attachment checkpoint mechanism-related genes were regulated, remarkably. As a result, novel gene regulations reported in this study in response to Emodin will give more information about its metabolism and antiproliferative effect, especially in ER + cells.

URI

https://hdl.handle.net/11511/89394

Journal

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

DOI

https://doi.org/10.1080/01635581.2021.1889622

Collections

Department of Biology, Article

Suggestions

OpenMETU
Core

Identification of gene mutations involved in drug resistance in liver cancer using RNA-SEQ data analysis Shojaei, Mona; Atalay, Rengül; Acar, Aybar Can; Department of Bioinformatics (2016) A significant concern in cancer research is the detection of cancer associated somatic mutations. Liver cancer is the 5th most common and 2nd deadliest cancer in the world. Several somatic mutations were previously reported in liver cancer but their relations to chemotherapeutic response was not studied in detail. In this study, the relationship between mutation status and drug treatment response of well-differentiated Huh7 and poorly-differentiated Mahlavu liver cancer cells were analyzed. The RNA-Seq data...
Preparation and characterization of poly(d,l-lactide-co-glycolide) microspheres for controlled release of anticancer drugs Eyövge, Gökçen; Gündüz, Ufuk; Department of Biotechnology (2005) Breast cancer is the most frequent type of cancer seen in woman. Chemotherapy is one of the most important treatments for breast cancer. However, systemic toxicity, drug resistance and unstable kinetics of the drug in the blood are serious problems of chemotherapy. The use of biodegradable polymers for controlled release of anticancer drugs has gained popularity in recent years. Controlled release of anticancer drugs from polymeric carriers has some advantages such as improvement in the efficiency of treatm...
Detection of Possible Significant Metabolites by Comparison of Metabolic Simulation Profiles of Healthy and Breast Cancer Tissues Akkuzu Özyeşer, Selin; Bülbül, Abdullah Alper; Başaran, Gül; Sezerman, Osman Uğur (Orta Doğu Teknik Üniversitesi Enformatik Enstitüsü; 2022-10) Breast cancer is the most frequent malignancy in women worldwide and is curable in ~70–80% of patients with early- stage, non- metastatic disease. In Breast cancer there are pathways related to Luminal A breast cancer, Luminal B breast cancer, HER2 positive breast cancer, Basal like/Triple negative breast cancer. The crucial signal transduction pathways in a breast cancerous cell includes pathways like PKB (protein kinase B), MAPK (mitogen-activated protein kinase), MTOR (mammalian target of rapamycin), Fas...
Identification of polymorphisms on the MDR1 gene among Turkish population and their effects on multidrug resistance in acute leukemia patients Kaya, P; Gündüz, Ufuk; Arpaci, F; Ural, AU; Guran, S (2005-09-01) Multidrug-resistance (MDR) phenotype is a serious limitation to the effective chemotherapeutic treatment of many cancer types, including leukemia. One of the most important proteins, the over-expression of which is responsible for the multidrug-resistance phenotype in many cancer types, is P-glycoprotein. This protein is the product of the MDR1 gene. In previous studies, single-nucleotide polymorphisms (SNPs) C3435T, G2677T, and T-129C in the MDR1 gene were shown to be correlated with lower P-glycoprotein e...
Novel ferrocenyl pyrazoles inhibit breast cancer cell viability via induction of apoptosis and inhibition of PI3K/Akt and ERK1/2 signaling Atmaca, Harika; Ozkan, Ayse Nur; Zora, Metin (2017-02-01) Despite the advances in early detection and targeted therapies, chemotherapy is still of vital importance in breast cancer treatment. However, development of drug resistance and serious side effects limits their usage. Thus, there is an urgent need for safer and more effective agents against breast cancer. We have previously described the synthesis of a number of pyrazole derivatives, and in the current study, we have investigated the effects of two different ferrocenyl pyrazole (FP) derivates, 5-ferrocenyl...

Citation Formats

E. Sakalli-Tecim, P. Uyar-Arpaci, and N. T. Güray, “Identification of Potential Therapeutic Genes and Pathways in Phytoestrogen Emodin Treated Breast Cancer Cell Lines via Network Biology Approaches,” NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, pp. 0–0, 2021, Accessed: 00, 2021. [Online]. Available: https://hdl.handle.net/11511/89394.